First-in-human Study of UX016 in GNEM
Trial details
- Registry ID
- NCT07511556
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| First-in-human Study of UX016 in GNEMNCT07511556 | RARE | Phase 1, Phase 2 | Recruiting | 2028-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |